DE69823931D1 - Chromatographieverfahren für Reinigung von IgG mit hoher Ausbeute und Virusinaktivierung - Google Patents
Chromatographieverfahren für Reinigung von IgG mit hoher Ausbeute und VirusinaktivierungInfo
- Publication number
- DE69823931D1 DE69823931D1 DE69823931T DE69823931T DE69823931D1 DE 69823931 D1 DE69823931 D1 DE 69823931D1 DE 69823931 T DE69823931 T DE 69823931T DE 69823931 T DE69823931 T DE 69823931T DE 69823931 D1 DE69823931 D1 DE 69823931D1
- Authority
- DE
- Germany
- Prior art keywords
- antibodies
- caprylate
- purification
- solution
- precipitate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0023—Heat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
- A61L2/0088—Liquid substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/23—Solid substances, e.g. granules, powders, blocks, tablets
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/20—Targets to be treated
- A61L2202/22—Blood or products thereof
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US879362 | 1997-06-20 | ||
US08/879,362 US5886154A (en) | 1997-06-20 | 1997-06-20 | Chromatographic method for high yield purification and viral inactivation of antibodies |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69823931D1 true DE69823931D1 (de) | 2004-06-24 |
DE69823931T2 DE69823931T2 (de) | 2005-06-16 |
Family
ID=25374006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69823931T Expired - Lifetime DE69823931T2 (de) | 1997-06-20 | 1998-06-09 | Chromatographieverfahren für Reinigung von IgG mit hoher Ausbeute und Virusinaktivierung |
Country Status (10)
Country | Link |
---|---|
US (5) | US5886154A (de) |
EP (1) | EP0893450B1 (de) |
JP (1) | JP4359347B2 (de) |
AT (1) | ATE267214T1 (de) |
AU (1) | AU749336B2 (de) |
CA (2) | CA2239237C (de) |
DE (1) | DE69823931T2 (de) |
DK (1) | DK0893450T3 (de) |
ES (1) | ES2221096T3 (de) |
PT (1) | PT893450E (de) |
Families Citing this family (102)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT403989B (de) | 1996-09-16 | 1998-07-27 | Immuno Ag | Verfahren zur herstellung eines plasmaprotein-hältigen arzneimittels |
US5886154A (en) * | 1997-06-20 | 1999-03-23 | Lebing; Wytold R. | Chromatographic method for high yield purification and viral inactivation of antibodies |
US6955917B2 (en) * | 1997-06-20 | 2005-10-18 | Bayer Healthcare Llc | Chromatographic method for high yield purification and viral inactivation of antibodies |
JP4685238B2 (ja) * | 1998-06-09 | 2011-05-18 | ツエー・エス・エル・ベーリング・アクチエンゲゼルシヤフト | 静脈投与用免疫グロブリン及び他の免疫グロブリン生成物の製造法 |
JP3096737B1 (ja) * | 1999-07-19 | 2000-10-10 | 工業技術院長 | ヒト・動物細胞培養液 |
SE0001128D0 (sv) * | 2000-03-30 | 2000-03-30 | Amersham Pharm Biotech Ab | A method of producing IgG |
US7332289B2 (en) * | 2001-03-09 | 2008-02-19 | Chugai Seiyaku Kabushiki Kaisha | Method of purifying protein |
US6893639B2 (en) * | 2001-10-19 | 2005-05-17 | Hemacare Corporation | Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates |
US20040022792A1 (en) * | 2002-06-17 | 2004-02-05 | Ralph Klinke | Method of stabilizing proteins at low pH |
DE10235168A1 (de) * | 2002-08-01 | 2004-02-12 | Aventis Pharma Deutschland Gmbh | Verfahren zur Reinigung von Preproinsulin |
ES2626268T3 (es) * | 2002-09-11 | 2017-07-24 | Chugai Seiyaku Kabushiki Kaisha | Método de purificación de proteínas |
US20040116676A1 (en) * | 2002-09-30 | 2004-06-17 | Hotta Joann | Methods for removal of contaminants from blood product solutions |
GB0304576D0 (en) * | 2003-02-28 | 2003-04-02 | Lonza Biologics Plc | Protein a chromatography |
US6984492B2 (en) * | 2003-09-05 | 2006-01-10 | Talecris Biotherapeutics, Inc. | Methods and compositions for treating herpes infections |
EP1532983A1 (de) | 2003-11-18 | 2005-05-25 | ZLB Bioplasma AG | Immunoglobulinpräparationen mit erhöhter Stabilität |
BRPI0507298A (pt) * | 2004-01-30 | 2007-07-03 | Suomen Punainen Risti Veripalv | processo para a produção de imunoglobulina segura a vìrus |
KR101206788B1 (ko) * | 2004-02-27 | 2012-11-30 | 옥타파르마 아게 | 정제된, 바이러스 안전한 항체 제제를 제공하는 방법 |
EP1786827A4 (de) * | 2004-05-14 | 2008-10-29 | Kirin Holdings Kk | Verfahren zur immunoglobulinaufreinigung |
EP1909831A4 (de) | 2005-06-14 | 2013-02-20 | Amgen Inc | Selbstpuffernde proteinformulierungen |
US7879332B2 (en) * | 2005-09-01 | 2011-02-01 | Plasma Technologies, Llc | Ultra-high yield intravenous immune globulin preparation |
US8293242B2 (en) * | 2005-09-01 | 2012-10-23 | Plasma Technologies, Llc | Ultra-high yield of alpha-1-anti-trypsin |
US20070049732A1 (en) * | 2005-09-01 | 2007-03-01 | Zurlo Eugene J | Ultra-high yield intravenous immune globulin preparation |
CN100339386C (zh) * | 2005-09-12 | 2007-09-26 | 大连三仪动物药品有限公司 | 动物用复合型免疫球蛋白的生产方法 |
US20070128693A1 (en) * | 2005-12-06 | 2007-06-07 | Advantek Serum Laboratories Limited3/F | Method for the inactivation and removal of dengue virus from biological samples |
ES2409844T3 (es) * | 2006-01-30 | 2013-06-28 | Grifols Therapeutics Inc. | Metodo para el tratamiento y la profilaxis de enfermedades relacionadas con la deposicion de amiloide utilizando IgM |
FR2899111B1 (fr) * | 2006-03-31 | 2010-09-03 | Lab Francais Du Fractionnement | Concentre d'immunoglobulines specifiques du chikungunya en tant que medicament. |
US20100234577A1 (en) * | 2006-06-14 | 2010-09-16 | Smithkline Beecham Corporation | Methods for purifying antibodies using ceramic hydroxyapatite |
WO2008036899A2 (en) * | 2006-09-22 | 2008-03-27 | Amgen Inc. | Methods for removing viral contaminants during protein purification |
US8883146B2 (en) | 2007-11-30 | 2014-11-11 | Abbvie Inc. | Protein formulations and methods of making same |
NZ709704A (en) * | 2007-11-30 | 2017-03-31 | Abbvie Biotechnology Ltd | Protein formulations and methods of making same |
AU2013204044B2 (en) * | 2007-11-30 | 2017-08-31 | Abbvie Biotechnology Ltd. | Protein formulations and methods of making same |
PT2271382E (pt) | 2008-04-15 | 2013-05-07 | Grifols Therapeutics Inc | Ultrafiltração em dois andares/diafiltração |
WO2009145722A1 (en) * | 2008-05-30 | 2009-12-03 | Ge Healthcare Bio-Sciences Ab | Separation method utilizing polyallylamine ligands |
EP3708581A3 (de) | 2009-05-27 | 2021-10-20 | Takeda Pharmaceutical Company Limited | Verfahren zur herstellung eines hochkonzentrierten immunglobulinpräparats zur subkutanen verwendung |
EP2445925A1 (de) * | 2009-06-25 | 2012-05-02 | Bristol-Myers Squibb Company | Proteinaufreinigung mittels präzipitation von caprylsäure (octansäure) |
IT1397061B1 (it) | 2009-12-28 | 2012-12-28 | Kedrion Spa | Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale. |
ES2716088T3 (es) | 2010-02-04 | 2019-06-10 | Csl Behring Ag | Preparado de inmunoglobulina |
EP2361636A1 (de) | 2010-02-26 | 2011-08-31 | CSL Behring AG | Immunglobulinpräparat und Aufbewahrungssystem für ein Immunglobulinpräparat |
GB201006753D0 (en) | 2010-04-22 | 2010-06-09 | Biotest Ag | Process for preparing an immunolobulin composition |
US8796430B2 (en) | 2010-05-26 | 2014-08-05 | Baxter International Inc. | Method to produce an immunoglobulin preparation with improved yield |
AU2011244947B2 (en) * | 2010-05-26 | 2012-06-07 | Takeda Pharmaceutical Company Limited | A method to produce an immunoglobulin preparation with improved yield |
US8772462B2 (en) | 2010-05-26 | 2014-07-08 | Baxter International Inc. | Removal of serine proteases by treatment with finely divided silicon dioxide |
AU2010202125B1 (en) | 2010-05-26 | 2010-09-02 | Takeda Pharmaceutical Company Limited | A method to produce an immunoglobulin preparation with improved yield |
KR101871683B1 (ko) | 2010-07-30 | 2018-06-27 | 이엠디 밀리포어 코포레이션 | 크로마토그래피 매질 및 방법 |
CA2812643A1 (en) | 2010-10-13 | 2012-04-19 | Octapharma Ag | Method for purification of complement factor h |
BR112013013884A2 (pt) * | 2010-12-06 | 2016-09-13 | Pall Corp | métodos de processamento contínuo para produtos biológicos |
DE102010054767B4 (de) | 2010-12-16 | 2013-02-21 | Previpharma Ag | Verfahren zur Trennung, Aufkonzentration und/oder Reinigung von (Blut)Plasmaprotein, Viren oder Virenbestandteilen |
DE102010054766B4 (de) | 2010-12-16 | 2012-08-30 | Previpharma Ag | Verfahren zur Trennung, Aufkonzentration oder Reinigung eines (Blut)Plasmaproteins oder Virenbestandteils aus einer Mischung |
EP2670429B1 (de) | 2011-02-04 | 2018-04-04 | Octapharma AG | Verfahren zur inaktivierung/entfernung von gerinnungsfaktoren mittels fällung |
FR2974301B1 (fr) | 2011-04-20 | 2013-08-23 | Lab Francais Du Fractionnement | Procede de preparation d'un produit plasmatique deplete en un ou plusieurs facteurs thrombogenes |
CN102250240B (zh) * | 2011-06-27 | 2013-07-31 | 山东泰邦生物制品有限公司 | 一种从血浆分离组分ⅰ+ⅲ中纯化人免疫球蛋白的方法 |
TWI629283B (zh) | 2012-02-23 | 2018-07-11 | 巴克斯歐塔公司 | 來自血漿中的免疫球蛋白之i-iv-1部分沉澱 |
KR20200126005A (ko) | 2012-02-29 | 2020-11-05 | 박스알타 인코퍼레이티드 | 말초 신경의 IgG 자극된 재수초화 |
EP2636684A1 (de) | 2012-03-09 | 2013-09-11 | CSL Behring AG | Vorbeugung von Infektionen |
CN104254542A (zh) | 2012-03-09 | 2014-12-31 | 瑞士杰特贝林生物制品有限公司 | 包含分泌-样免疫球蛋白的组合物 |
EP2636681A1 (de) | 2012-03-09 | 2013-09-11 | CSL Behring AG | Verfahren zur Anreicherung von IgA |
ES2381828B1 (es) | 2012-03-20 | 2012-11-16 | Grifols, S.A. | PROCEDIMIENTO PARA OBTENER UNA COMPOSICION DE IgG MEDIANTE TRATAMIENTO TERMICO |
CN107188926B (zh) * | 2012-06-29 | 2021-02-09 | Emd密理博公司 | 在蛋白纯化过程中灭活病毒的方法 |
AU2013205138B2 (en) * | 2012-08-09 | 2015-06-25 | Grifols, S.A. | Caprylate Viral Deactivation |
PE20191815A1 (es) | 2012-09-07 | 2019-12-27 | Coherus Biosciences Inc | Formulaciones acuosas estables de adalimumab |
EP2953965A4 (de) * | 2013-02-06 | 2016-09-14 | Agency Science Tech & Res | Proteinaufreinigungsverfahren |
MX2015012114A (es) | 2013-03-08 | 2016-01-12 | Genzyme Corp | Fabricacion continua integrada de principios activos proteinicos terapeuticos. |
DK3016976T3 (da) * | 2013-07-01 | 2020-12-07 | Csl Behring Ag | Proces |
KR102356757B1 (ko) | 2013-10-18 | 2022-02-03 | 노바셉 이큅먼트 솔루션즈 | 단백질 정제 |
AU2014350370B2 (en) | 2013-11-15 | 2017-04-13 | Novartis Ag | Removal of residual cell culture impurities |
TWI709569B (zh) | 2014-01-17 | 2020-11-11 | 美商健臻公司 | 無菌層析樹脂及其用於製造方法的用途 |
TWI709570B (zh) | 2014-01-17 | 2020-11-11 | 美商健臻公司 | 無菌層析法及製法 |
KR101917197B1 (ko) * | 2014-03-11 | 2018-11-09 | 주식회사 녹십자홀딩스 | 면역글로불린의 정제방법 |
US10435670B2 (en) * | 2014-04-15 | 2019-10-08 | Boehringer Ingelheim International Gmbh | Methods, apparatuses, and systems for continuously inactivating a virus during manufacture of a biological product |
WO2015166072A1 (en) * | 2014-04-30 | 2015-11-05 | Novo Nordisk A/S | Methods for the purification of proteins using caprylic acid |
US10207225B2 (en) | 2014-06-16 | 2019-02-19 | Emd Millipore Corporation | Single-pass filtration systems and processes |
WO2015195453A2 (en) | 2014-06-16 | 2015-12-23 | Emd Millipore Corporation | Methods for increasing the capacity of flow-through processes |
SG10201908746UA (en) | 2014-06-25 | 2019-10-30 | Emd Millipore Corp | Compact spiral-wound filter elements, modules and systems |
SG11201508665QA (en) | 2014-08-29 | 2016-03-30 | Emd Millipore Corp | Processes For Filtering Liquids Using Single Pass Tangential Flow Filtration Systems AndTangential Flow Filtration Systems With Recirculation of Retentate |
KR102079585B1 (ko) | 2014-08-29 | 2020-02-21 | 이엠디 밀리포어 코포레이션 | 잔류물의 재순환을 이용한 싱글 패스 접선 유동 여과 시스템 및 접선 유동 여과 시스템 |
CA2954425C (en) | 2014-09-02 | 2019-05-07 | Emd Millipore Corporation | High surface area fiber media with nano-fibrillated surface features |
WO2016073401A1 (en) | 2014-11-03 | 2016-05-12 | Bristol-Myers Squibb Company | Use of caprylic acid precipitation for protein purification |
US9556253B2 (en) | 2014-12-02 | 2017-01-31 | Hemarus Therapeutics Limited | Process for increased yield of immunoglobulin from human plasma |
WO2016093926A1 (en) | 2014-12-08 | 2016-06-16 | Emd Millipore Corporation | Mixed bed ion exchange adsorber |
US9913903B2 (en) | 2015-08-06 | 2018-03-13 | Grifols Worldwide Operations Limited | Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM |
US10570194B2 (en) | 2015-08-06 | 2020-02-25 | Grifols Worldwide Operations Limited | Method for treating infectious diseases using a composition comprising plasma-derived immunoglobulin M (IgM) |
TR201905974T4 (tr) | 2015-08-31 | 2019-05-21 | Inst Grifols S A | İmmünoglobuli̇nleri̇n hazirlanmasi i̇çi̇n yöntem |
CN105126100B (zh) * | 2015-09-23 | 2021-01-26 | 成都蓉生药业有限责任公司 | 一种富含IgM的人免疫球蛋白制剂及其制备方法 |
US11229702B1 (en) | 2015-10-28 | 2022-01-25 | Coherus Biosciences, Inc. | High concentration formulations of adalimumab |
US11071782B2 (en) | 2016-04-20 | 2021-07-27 | Coherus Biosciences, Inc. | Method of filling a container with no headspace |
JP6370853B2 (ja) * | 2016-09-26 | 2018-08-08 | インスティトゥト グリフォルス,ソシエダ アノニマ | 免疫グロブリンの調製方法 |
BR112019007858A2 (pt) | 2016-10-21 | 2019-07-02 | Amgen Inc | formulações farmacêuticas e métodos para produzir as mesmas |
BE1025090B1 (fr) * | 2017-03-30 | 2018-10-29 | Univercells Sa | Procede et kit de purification de proteines |
US11312746B2 (en) | 2018-05-17 | 2022-04-26 | Csl Behring Ag | Method and system of protein extraction |
WO2020046602A1 (en) | 2018-08-31 | 2020-03-05 | Genzyme Corporation | Sterile chromatography resin and use thereof in manufacturing processes |
US20230002444A1 (en) | 2019-11-20 | 2023-01-05 | Csl Behring Ag | Method for extracting a protein from a precipitate and method for precipitating impurities |
KR20220161332A (ko) | 2020-03-31 | 2022-12-06 | 다케다 야쿠힌 고교 가부시키가이샤 | C-1 억제제 고갈 혈장으로부터 면역글로불린 조제물을 제조하는 방법 |
EP4157351A1 (de) | 2020-05-27 | 2023-04-05 | Grifols Worldwide Operations Limited | Verfahren zur behandlung von virusinfektionen mit ivig und konvaleszentem plasma |
JP2023527864A (ja) | 2020-06-03 | 2023-06-30 | グリフォルス・ワールドワイド・オペレーションズ・リミテッド | 過免疫igg及び/又はigm組成物及びその調製方法及び過免疫ヒト血漿をドナーから得る方法 |
CA3183021A1 (en) | 2020-07-10 | 2022-01-13 | Myles Lindsay | Method for obtaining a composition comprising human plasma-derived immunoglobulin m |
CN111991571B (zh) * | 2020-08-12 | 2022-04-05 | 湖州师范学院 | 一种柱上低pH病毒灭活的方法 |
CN112500477B (zh) * | 2020-12-05 | 2023-06-06 | 贵州泰邦生物制品有限公司 | 一种快速从血浆提取人免疫球蛋白的方法 |
CA3220221A1 (en) * | 2021-05-26 | 2022-12-01 | Ibrahim EL MENYAWI | Plasma fractionation by continuous extraction |
CA3223881A1 (en) | 2021-07-29 | 2023-02-02 | Roopsee ANAND | Method of purifying immunoglobulin g and uses thereof |
WO2023194944A1 (en) | 2022-04-08 | 2023-10-12 | Csl Behring Ag | Methods of sanitizing and/or regenerating a chromatography medium |
BE1029863B1 (nl) * | 2022-05-10 | 2023-05-12 | Prothya Biosolutions Belgium | WERKWIJZEN VOOR HET PRODUCEREN VAN IMMUNOGLOBULINE G (IgG) PREPARATEN EN/OF OPLOSSINGEN |
CH719843A2 (de) | 2022-06-28 | 2024-01-15 | Csl Behring Ag | Verfahren zur Bestimmung der Konzentration eines Analyten in einer Probe, die aus der Resuspendierung von Cohn-Fraktion V oder Kistler/Nitschmann-Präzipitat C erhalten wurde |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2190437B1 (de) | 1972-07-05 | 1975-08-08 | Merieux Inst | |
US4156681A (en) | 1974-03-28 | 1979-05-29 | Plasmesco Ag | Process for isolating albumin from blood |
US4136094A (en) | 1977-08-31 | 1979-01-23 | The Regents Of The University Of Minnesota | Preparation of intravenous human and animal gamma globulins and isolation of albumin |
US4396608A (en) | 1981-08-24 | 1983-08-02 | Cutter Laboratories | Intravenously injectable immune serum globulin |
JPS5855432A (ja) | 1981-09-29 | 1983-04-01 | Fujirebio Inc | 静脈注射用免疫グロブリンの製法 |
CA1201063A (en) * | 1982-07-20 | 1986-02-25 | Winnipeg Rh Institute Inc., (The) | Process for preparing purified immune globulin (igg) |
US4434093A (en) | 1982-07-26 | 1984-02-28 | Ortho Diagnostic Systems Inc. | Methods for preparation of HBs Ag free gamma globulins |
US4639513A (en) * | 1984-02-02 | 1987-01-27 | Cuno Inc. | Intravenously injectable immunoglobulin G (IGG) and method for producing same |
US4534972A (en) | 1983-03-29 | 1985-08-13 | Miles Laboratories, Inc. | Protein compositions substantially free from infectious agents |
US4540573A (en) | 1983-07-14 | 1985-09-10 | New York Blood Center, Inc. | Undenatured virus-free biologically active protein derivatives |
US4983722A (en) * | 1988-06-08 | 1991-01-08 | Miles Inc. | Removal of protein A from antibody preparations |
DE3821295A1 (de) * | 1988-06-24 | 1989-12-28 | Kernforschungsz Karlsruhe | Verfahren zur abtrennung von technetium, ruthenium und palladium aus kernbrennstoff-loesungen |
US4939176A (en) * | 1988-12-20 | 1990-07-03 | Miles Inc. | Viral inactivation process |
DE3927111C3 (de) | 1989-08-17 | 1994-09-01 | Biotest Pharma Gmbh | Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate |
DE3927112C1 (de) | 1989-08-17 | 1990-10-25 | Biotest Pharma Gmbh, 6072 Dreieich, De | |
US5177194A (en) * | 1990-02-01 | 1993-01-05 | Baxter International, Inc. | Process for purifying immune serum globulins |
JPH0778025B2 (ja) | 1990-03-20 | 1995-08-23 | 日本赤十字社 | 免疫グロブリンgの製造方法 |
ATE122054T1 (de) * | 1990-03-22 | 1995-05-15 | Biotest Pharma Gmbh | Verfahren zur herstellung eines intravenös verträglichen immunglobulin-g-präparates. |
US5110910A (en) * | 1991-03-25 | 1992-05-05 | Miles Inc. | Virucidal euglobulin precipitation |
US5164587A (en) | 1991-09-09 | 1992-11-17 | Harbor Branch Oceanographic Institution, Inc. | Polarimetric parameter measurement systems and methods for measuring a plurality of parameters |
US5258177A (en) * | 1991-12-10 | 1993-11-02 | Alpha Therapeutic Corporation | IgA preparation and process of making the same |
US5561115A (en) | 1994-08-10 | 1996-10-01 | Bayer Corporation | Low temperature albumin fractionation using sodium caprylate as a partitioning agent |
US5886154A (en) * | 1997-06-20 | 1999-03-23 | Lebing; Wytold R. | Chromatographic method for high yield purification and viral inactivation of antibodies |
-
1997
- 1997-06-20 US US08/879,362 patent/US5886154A/en not_active Expired - Lifetime
-
1998
- 1998-04-02 JP JP10535298A patent/JP4359347B2/ja not_active Expired - Lifetime
- 1998-05-29 CA CA002239237A patent/CA2239237C/en not_active Expired - Lifetime
- 1998-05-29 CA CA2676074A patent/CA2676074C/en not_active Expired - Lifetime
- 1998-06-09 DK DK98110526T patent/DK0893450T3/da active
- 1998-06-09 EP EP98110526A patent/EP0893450B1/de not_active Expired - Lifetime
- 1998-06-09 DE DE69823931T patent/DE69823931T2/de not_active Expired - Lifetime
- 1998-06-09 PT PT98110526T patent/PT893450E/pt unknown
- 1998-06-09 AT AT98110526T patent/ATE267214T1/de active
- 1998-06-09 ES ES98110526T patent/ES2221096T3/es not_active Expired - Lifetime
- 1998-06-10 AU AU70099/98A patent/AU749336B2/en not_active Expired
-
1999
- 1999-03-17 US US09/270,724 patent/US6307028B1/en not_active Expired - Lifetime
-
2001
- 2001-10-09 US US09/973,141 patent/US20020177693A1/en not_active Abandoned
-
2007
- 2007-10-17 US US11/873,878 patent/USRE43655E1/en not_active Expired - Lifetime
-
2012
- 2012-07-19 US US13/553,364 patent/USRE44558E1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
USRE43655E1 (en) | 2012-09-11 |
CA2676074A1 (en) | 1998-12-20 |
AU749336B2 (en) | 2002-06-27 |
DE69823931T2 (de) | 2005-06-16 |
EP0893450B1 (de) | 2004-05-19 |
US5886154A (en) | 1999-03-23 |
PT893450E (pt) | 2004-09-30 |
USRE44558E1 (en) | 2013-10-22 |
JPH1129494A (ja) | 1999-02-02 |
US20020177693A1 (en) | 2002-11-28 |
CA2239237C (en) | 2010-02-02 |
CA2239237A1 (en) | 1998-12-20 |
ATE267214T1 (de) | 2004-06-15 |
JP4359347B2 (ja) | 2009-11-04 |
DK0893450T3 (da) | 2004-09-13 |
ES2221096T3 (es) | 2004-12-16 |
EP0893450A1 (de) | 1999-01-27 |
AU7009998A (en) | 1998-12-24 |
CA2676074C (en) | 2015-10-06 |
US6307028B1 (en) | 2001-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69823931D1 (de) | Chromatographieverfahren für Reinigung von IgG mit hoher Ausbeute und Virusinaktivierung | |
DK450785A (da) | Fremgangsmaade til fremstilling af et koncentrat af antihaemofilisk faktor med hoej renhed | |
DE3778086D1 (de) | Herstellungsverfahren von quaternaeren ammoniumhydroxiden von hoher reinheit. | |
ES2139227T3 (es) | Concentrado de fibrinogeno obtenido de plasma sanguineo, procedimiento e instalacion para su preparacion. | |
JPH07267997A (ja) | IgG− モノクロナール抗体の精製方法及びその使用方法 | |
NZ226651A (en) | Ion exchange protein separation method characterised by adjusting ph so that the pure protein and the impurity are oppositely charged | |
EP0309787A3 (en) | Process for producing a highly purified, virus-free and biologically active transferrin preparation | |
AU2253392A (en) | Therapeutic fragments of von willebrand factor | |
DE69631229D1 (de) | Herstellung von virusinaktivierten Intravenös injektierbaren Globulin aus Immunserum | |
DE3062792D1 (en) | A process in purification and concentration of the factor viii-complex | |
Trupin et al. | Variation in prolyl hydroxylase activity of keloid-derived and normal human fibroblasts in response to hydrocortisone and ascorbic acid | |
DE69303941T2 (de) | Verfahren zur Herstellung von hochreinem Fibrinogen | |
DE59813491D1 (de) | Verfahren zur Herstellung eines eine Hyaluronidase enthaltenden Präparats | |
KR100369582B1 (ko) | 재조합알파-인터페론의정제방법 | |
SE435787B (sv) | Forfarande for framstellning av immunoglobulinderivat | |
DE3170868D1 (en) | Process for the preparation of highly purified antihemophilic factor | |
KR890001128B1 (ko) | 조 임파구 인터페론의 정제방법 | |
JPS61234792A (ja) | マウスインタ−フエロンの精製法 | |
KR930006151A (ko) | 지렁이로부터 프로테아제를 분리 정제하는 방법 | |
FR2623506B1 (fr) | Procede de preparation de synthons peptidiques | |
JPS61181395A (ja) | マウスインタ−フエロンの精製法 | |
KR910016926A (ko) | 인간 β-인터페론의 정제방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8365 | Fully valid after opposition proceedings |